Aurobindo Pharma share buyback: Company shares are trading green after the announcement, despite weak trends on Dalal Street.Aurobindo Pharma share buyback: The Indian pharma major has announced a share buyback of up to ₹800 crore. The company board took this decision in a meeting held on Monday, 6 April 2026. The company board also declared the Aurobindo Pharma buyback price at ₹1,475, offering a 10% premium, as the Aurobindo Pharma share price is currently oscillating around ₹1,335 apiece on the NSE.
The company also made it clear that the offer is available to all investors who held company shares on 17 April 2026, the Aurobindo Pharma share buyback record date. The buyback plan will be executed through the tender process.
Informing the Indian exchanges about the share buyback move, Aurobindo Pharma said, “In continuation of our letter dated March 31, 2026, and in terms of Regulation 30 of Listing Regulations, we wish to inform you that the Board of the Aurobindo Pharma Limited (“Company”), at its meeting held today (i.e., April 6, 2026), has inter-alia, considered and approved: the buyback of up to 54,23,728 (Fifty four lakhs twenty three thousand seven hundred and twenty eight only) fully paid-up equity shares of the Company, each having a face value of INR 1/- (Indian Rupee one only) (“Equity Shares”), representing up to 0.93% of the total number of equity shares in the paid-up equity share capital of the Company, at a price of INR 1,475/- (Indian Rupees one thousand four hundred and seventy five only) per Equity Share (“Buyback Price”) payable in cash for an aggregate amount up to INR 800,00,00,000/-(Indian Rupees eight hundred crores only) (“Buyback Size”) being 3.93% and 2.62% of the aggregate of the total paid-up equity share capital and free reserves (including securities premium) as per the latest audited standalone and consolidated financial statements of the Company as at March 31, 2025, respectively.”
The company board also approved the record date for share buyback, saying, “We wish to inform you that the Board of the Aurobindo Pharma Limited (“Company”), at its meeting held today (i.e., April 6, 2026), has inter-alia, considered and approved April 17, 2026 (“Record Date”) as the record date for the purpose of determining the entitlement and the names of equity shareholders who would be eligible to participate in the buyback, in accordance with Regulation 42 of the Listing Regulations and Regulation 9(i) of the Buyback Regulations.”
The Buyback Size does not include transaction costs viz. brokerage costs, fees, turnover charges, applicable taxes on this, securities transaction tax, goods and services tax, stamp duty, etc., and expenses incurred or to be incurred for the buyback like filing fees payable to the Securities and Exchange Board of India (“SEBI”), advisors/ legal fees, public announcement publication expenses, printing and dispatch expenses and other incidental and related expenses, etc.
The buyback is proposed to be made from all of the equity shareholders / beneficial owners of the Company, including the promoters and members of the promoter group of the Company (as defined under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011), who hold Equity Shares as of the record date (as mentioned below), on a proportionate basis through the “tender offer” route, in accordance with the provisions contained in the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (“Buyback Regulations”) and the Companies Act, 2013.
Asit Manohar has nearly two decades of experience in the mainstream media. In this period, he has served esteemed media organisations like NDTV Profit, The Economic Times, and Zee Business. He has been working at LiveMint Digital since April 2021. During these two decades of journey in mainstream media, Asit has mainly covered external affairs, markets and personal finance. However, his earliest beats include railways, SME, MSME, and politics (Congress beat). Some of his features on political, economic, and foreign policy are documented in the parliamentary records.
<br><br>
While pursuing his MA (Mass Communication, Session 2004-06), Asit began his media career as a stringer at All India Radio in Varanasi. At AIR Varanasi, Asit worked with the Gyanvani, Yuvvani and Vividh Bharti teams. After working for nearly one year at AIR Varanasi, he shifted to print journalism and started working as a stringer for the HT Media Ltd, Varanasi. At HT Media Ltd in Varanasi, he covered the BHU beat.
<br><br>
Asit has also worked with some brokerage houses. He has worked with Religare Broking and India Infoline, where he assisted the research team in developing and executing trade strategies for intraday cash, F&O, and commodities.
<br><br>
Asit is a Gold Medalist in MA (Mass Communication) from BHU, Varanasi. He did his BSc. (Hons) in Mathematics from Magadh University, Bodh Gaya. Asit was a National Talent Scholarship holder during his senior secondary studies (1988-91).